1. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation
   Annika Wilhelm et al, 2016, The Journal of Pathology CrossRef
2. Fn14·TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog
   Tatyana B. Prigozhina et al, 2017, Cancer Letters CrossRef
3. NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients
   Jun-yan Liu et al, 2019, Cell Death & Disease CrossRef
4. A potential fate decision landscape of the TWEAK/Fn14 axis on stem and progenitor cells: a systematic review
   Sijia Wang et al, 2022, Stem Cell Research & Therapy CrossRef
5. RG7212 Anti-TWEAK mAb Inhibits Tumor Growth through Inhibition of Tumor Cell Proliferation and Survival Signaling and by Enhancing the Host Antitumor Immune Response
   Xuefeng Yin et al, 2013, Clinical Cancer Research CrossRef
6. TWEAK–Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome
   Jonay Poveda et al, 2021, The Journal of Pathology CrossRef
7. Immunohistochemical expression of tumor necrosis factor‐like weak inducer of apoptosis and fibroblast growth factor‐inducible immediate early response protein 14 in oral squamous cell carcinoma and its implications
   Swetha Acharya et al, 2019, Journal of Investigative and Clinical Dentistry CrossRef
8. TWEAK/Fn14 axis: The current paradigm of tissue injury-inducible function in the midst of complexities
   Linda C. Burkly, 2014, Seminars in Immunology CrossRef
9. Development of Human Serine Protease-Based Therapeutics Targeting Fn14 and Identification of Fn14 as a New Target Overexpressed in TNBC
   Hong Zhou et al, 2014, Molecular Cancer Therapeutics CrossRef
10. Tumor necrosis factor-like weak inducer of apoptosis expression in healthy oral mucosa, oral dysplasia and oral squamous cell carcinoma
    Swetha Acharya et al, 2019, Journal of Oral and Maxillofacial Pathology CrossRef
11. Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-κB axis
    Feng Guan et al, 2017, Oncotarget CrossRef
12. Decreased expression of TNFRSF12A in thyroid gland cancer predicts poor prognosis
    Zeng-Hong Wu et al, 2020, Medicine CrossRef
13. Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer
    Ying Sun et al, 2016, Oncology Reports CrossRef
14. Disruption of the TWEAK/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice
    Takuhito Sezaki et al, 2017, World Journal of Gastroenterology CrossRef
15. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling
    Evan M Cherry et al, 2015, Molecular Cancer CrossRef
16. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Promotes Hepatic Stellate Cells Migration via Canonical NF-κB/MMP9 Pathway
    Mingcui Xu et al, 2016, PLOS ONE CrossRef
17. Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy
    Olena Zaitseva et al, 2022, Frontiers in Pharmacology CrossRef
18. miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma
    Rui-Da Xu et al, 2018, International Journal of Immunopathology and Pharmacology CrossRef
19. TWEAK/Fn14 signaling in tumors
    Guanglei Hu et al, 2017, Tumor Biology CrossRef